Client:
Top 10 Pharmaceutical Company
Challenge:
A global biopharmaceutical company requested expert support to define a fit-for-purpose early access program (EAP) for an innovative oncology asset. This included understanding possible demand and a strategy to address patient needs before regulatory approval and reimbursement.
Impact:
- Delivered early access readiness roadmap
- Strengthened internal stakeholder trust through a clear and compliant EAP plan
- Ensured that patient needs are addressed when early access is required
Our Role:
- Defined various types of EAPs to align communication between different countries
- Developed a tiered EAP strategy integrating ethical, logistical, and reputational considerations
- Aligned global and local cross-functional teams on risk-benefit tradeoffs
